Bhagiradha Chemicals & Industries Ltd. · NSE:BHAGCHEM

Bhagiradha Chemicals & Industries — H1FY26 Earnings Presentation

37 slides from Bhagiradha Chemicals & Industries's earnings presentation, Nov 11, 2025

  1. Slide 1: Stock exchange cover letter for investor presentation

    Ref: BCIL/SE/2025/82 November 11, 2025 To, To, The Secretary, The Manager, BSE Limited, Listing Department, Phiroze Jeejeebhoy Towers, National Stock Exchange of India Limited, Dalal Street, Exchange Plaza, C-1, G Block, Bandra-Kurla, Mumbai - 400 001 Complex, Bandra (East), Mumbai – 400 051 Scrip C

  2. Slide 2: Investor Presentation Q2 & H1FY26

    Bhagiradha Chemicals & Industries Limited Investor Presentation Q2 & H1FY26 Rooted in Chemistry, Rising with Promise

  3. Slide 3: Safe Harbor

    Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Bhagiradha Chemicals and Industries Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or sub

  4. Slide 4: Q2 & H1FY26 Results Highlights

    Q2 & H1FY26 Results Highlights

  5. Slide 5: H1FY26 Consolidated Financial Highlights

    H1FY26 Consolidated Financial Highlights Volumes: Revenue From Operations EBITDA PAT Rs. In Crores • Have seen close to double digit growth in volumes, supported by increasing trend in demand +23% +11% -15% 263.9 24.0 11.1 Price Realizations: 21.7 9.5 215.1 • Average price realizations have bottomed

  6. Slide 6: Q2FY26 Consolidated Financial Highlights

    Q2FY26 Consolidated Financial Highlights Volumes: Revenue From Operations EBITDA PAT • Achieved close to double digit growth in volumes, Rs. In Crores supported by increasing trend in demand +35% +55% +1% Price Realizations: 140.1 15.1 5.4 5.5 123.8 • Average price realizations for certain products

  7. Slide 7: Consolidated Profit & Loss Statement

    Consolidated Profit & Loss Statement Particulars (Rs. In Cr.) Q2FY26 Q2FY25 YoY Q1FY26 QoQ H1FY26 H1FY25 YoY FY25 Revenue From Operations 140.1 103.7 35% 123.8 13% 263.9 215.1 23% 440.5 Cost of Raw Materials Consumed 91.4 63.1 82.3 173.6 132.6 278.1 Gross Profit 48.7 40.7 20% 41.5 17% 90.3 82.5 9% 1

  8. Slide 8: Consolidated Balance Sheet

    Consolidated Balance Sheet Assets (Rs. In Cr.) Sept-25 Mar-25 Equity & Liabilities (Rs. In Cr.) Sept-25 Mar-25 Non- Current Assets (A) 647.5 558.3 Equity (A) 689.7 682.2 Property, Plant & Equipment 248.0 238.2 Equity Share Capital 13.0 13.0 Capital Work in Progress 377.4 287.8 Other Equity 676.7 669

  9. Slide 9: Consolidated Cash Flow Statement

    Consolidated Cash Flow Statement Particulars (Rs. In Cr.) Sept-25 Sept-24 Net Profit Before Tax 10.0 17.4 Adjustments for: Non -Cash Items / Other Investment or Financial Items 12.0 3.7 Operating profit before working capital changes 22.0 21.2 Changes in working capital -22.8 -51.7 Cash generated fr

  10. Slide 10: Management Commentary

    Management Commentary Commenting on the performance Mr. A. Arvind Kumar, Executive Director & CEO said: “We entered FY26 with signs of recovery in both volumes and price realizations. While pricing pressures persist in certain product categories, we believe prices have largely bottomed out and are b

  11. Slide 11: Key Business Update

    Key Business Update Capex Update of the H1FY26 Key Highlights Subsidiary • We are witnessing a strong recovery in volumes • Total expansion plan of ~Rs. 800 crore, including a since H2FY25, driven by rising demand and ~Rs. 70 crore for solar project expanding market reach • Phase 1 of the project im

  12. Slide 12: Company Overview

    Company Overview Rising with Promise

  13. Slide 13: Bhagiradha at a Glance

    Bhagiradha at a Glance 30+ years Establishment Product Portfolio Manufacturing Facilities Established in 1993 by visionary 2 manufacturing facilities at Andhra Pradesh entrepreneur, late Sri. S. Koteswara Rao (existing) & Karnataka (upcoming) who was well recognised scientist in Established Capacity

  14. Slide 14: Transformational Journey so far

    Transformational Journey so far BCIL 1.0 BCIL 2.0 FY04 FY11 FY19 FY25 Revenue: Revenue: Revenue: Revenue: Growth Phase 52 crores 60 crores 384 crores 441 crores 1993 - 2004 2005 - 2011 2012 - 2019 2020 - 2025 • 2012: Backward integration of • 2020: Backward integration of • 1993: Founded by Sri Kote

  15. Slide 15: Level of backward integration achieved

    With Product Launches at Regular Intervals *Products Capability High Current Products Can be revived basis capacity availability Manufactured as a campaign Discontinued due to commercial reasons 32 2,6-dichloroaniline H Diafenthiuron I F I H I Acequinocyl Azoxystrobin H Triclopyr H Fipronil I 4 ADMP

  16. Slide 16: and Established Customer Base

    and Established Customer Base No single customer contributes more than 20% of the sales Customers 130 113 111 110 Relationship with 100+ active customers Various partnerships for registrations 98 with maximum customer retention in countries like USA, Brazil, EU etc Relationship of average tenure of

  17. Slide 17: Along with Strong Market Presence

    Along with Strong Market Presence Andhra Pradesh Presence in 20+ countries - Serving the farming communities worldwide (Existing Plant) Manufacturing Plants in Andhra Pradesh & Karnataka (India) • No. of production blocks: 3 production blocks with 4 process lines • Capacity: 3,250 MT / p. a. Corpora

  18. Slide 18: Bhagiradha's Competitive Edge

    Bhagiradha’s Competitive Edge

  19. Slide 19: R&D serves as a growth engine, backed by strong infrastructure

    R&D serves as a growth engine, backed by strong infrastructure Well-established R&D centre – Approved by Department of Scientific and Industrial Research & Ministry of Technology and Science, Government of India R&D center, 8 Synthesis labs with Pilot and semi 60+ Chemists R&D Facility – Synthesis,

  20. Slide 20: Creating Entry Barrier: Backward Integration

    Creating Entry Barrier: Backward Integration Input 13 N-6 (A) N-5 (A) N-4 (B) N-3 (A) Backward integration to increase to N-9 level with 16 process stages by FY 26, thus Input 14 Input 12 Input 11 Input 7 & 8 Input 4 Input 3 increasing margin Input 9 & 10 N-3 (B) N-2 (A) N-1 (A) Product 1 Input 5 &

  21. Slide 21: Environmentally Responsible & Validated by Customers & External Agencies

    Environmentally Responsible & Validated by Customers & External Agencies Greenery Around Plant Audit by Reputed External Effluent Treatment Plant Electro Oxidation Plant Agencies • Zero Liquid Discharge (ZLD) ETP which recycles water for reuse. • Effluent treatment process based • Ground water ~30%

  22. Slide 22: Social Responsibility and Workplace Safety

    Social Responsibility and Workplace Safety Our CSR initiatives focus on education, healthcare, and skill development, with this year’s funds directed towards reconstructing and repairing a building for future use in skill development and training Promoting Education, Healthcare & Training & Workplac

  23. Slide 23: BCIL 2.0 Growth Investment

    BCIL 2.0 Growth Investment Rising with Promise

  24. Slide 24: Investment in Subsidiary

    Investment in Subsidiary Bhagiradha Chemicals & Industries Limited (BCIL) Total Investments of Rs. 800+ crores under the Expansion Program Bheema Fine Chemicals Private Limited (100% subsidiary) Land size of 34 acres: Higher level of 9,002 MT New manufacturing facility at Kadechur Industrial backwar

  25. Slide 25: will have Exponential Growth

    will have Exponential Growth Expansion of Rs. 800+ crores in Phases Greenfield Capacity Expansion Allocation of Funds Backward Integration • Land & Building: ~190 crores Direct infusion of New Product Introduction ~450+ crores Convertible equity from BCIL Warrants • Plant & Machinery: ~540 crores ~

  26. Slide 26: and Growth Strategies

    and Growth Strategies • Increase level of backward integration in existing key molecules so Increase level of Backward as to have minimum dependency on Chinese imports thereby ✓ Leveraging existing relationships to capture Integration improving the margins markets & adding new customers through comp

  27. Slide 27: Thank You!

    Company: Investor Relations Advisors: CIN: L24219TG1993PLC015963 CIN: U74140MH2010PTC204285 Mrs. Sharanya. M - Company Ms. Neha Shroff / Mr. Mayur Pednekar neha.shroff@sgapl.net Secretary & Compliance Officer cs@bhagirad.com neha.shroff@sgapl.net / mayur.Pednekar@sgapl.net cs@bhagirad.com mayur.Pedn

  28. Slide 28: Annexure

    Rising with Promise Annexure

  29. Slide 29: Founded by Well-recognised Scientist

    Founded by Well-recognised Scientist • Late Sri Koteswara Rao was one of the well-recognized scientists in South India. His years of hard work, research and innovative mindset have spurred the growth and success of BCIL. • He held a postgraduate degree in Chemical Engineering from IIT Madras. • He s

  30. Slide 30: Have Strong Leadership Team

    Have Strong Leadership Team S. Chandra Sekhar A. Arvind Kumar B. Krishna Mohan Rao Promoter & Managing Director Executive Director & CEO Chief Financial Officer • Sri. S. Chandra Sekhar is a Chemical Engineer • Sri. A. Arvind Kumar holds a Master's degree in • Graduate in Arts and Associate of the I

  31. Slide 31: Experienced Board Members: Independent Directors

    Experienced Board Members Independent Directors Kishor Shah GSV Krishna Rao Dr. G. Aruna Non-Executive Chairman Non-Executive Director Non-Executive Women Director • He is a Fellow Member of the Institute of Chartered • An Independent and Non-Executive Director on the • She is B. Tech in Chemical En

  32. Slide 32: Historical Performance

    ‘5 BHAGIRADHA CH EMICALS Historical Performance

  33. Slide 33: Financial Snapshot

    Financial Snapshot Revenue From Operations (Rs. In Cr.) EBITDA (Rs. In Cr.) Profit After Tax (Rs. In Cr.) 502 77 45 436 441 68 408 36 318 47 43 37 23 18 14 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 Revenue Break-up (%) EBITDA (%) PAT (%) Export 3% 16% 9% 15% 15% 8% 7

  34. Slide 34: Expense Snapshot

    Expense Snapshot Capacity Utilization (%) Raw Material (% to Sales) Employee Cost (% to Sales) 89% 90% 63% 64% 62% 63% 9% 87% 60% 8% 85% 6% 6% 5% 72% FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 Power & Fuel Cost (% to sales) Other Expenditure (% to Sales) 10% 19% 10% 8% 8% 7% 11% 8% 8% 8% FY21

  35. Slide 35: Key Ratios

    Key Ratios Return on Capital Employed (%) Asset turnover ratio Working Capital (No. of Days) 22% 2.0 1.9 99 132 164 73 192 18% 19% days days days days days 1.5 1.4 1.3 7% 170 165 3% 144 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 122 Return on Equity (%) Debt to Equity Ratio 106 92 94 96 97 87

  36. Slide 36: Corporate Action Update – Convertible warrants issued on preferential basis

    Corporate Action Update – Convertible warrants issued on preferential basis Warrants issued in November 2023 Particulars Remarks Subdivision of Shares: May 2024: No. of shares Issued & 25,61,425 Equity shares of Rs. 10/- each Allotted The existing equity shares of the Company of face value of Rs. 10

  37. Slide 37: Capital Raise History

    Capital Raise History Corporate Action Preferential Allotment Right Issue Preferential Allotment Total Issue Size Rs. 59 crores Rs. 84 crores Rs. 341 crores 341 84 59 17 19 15 2017-19 2022 2023-25 Total Issue size Promoters contribution Rs. In Crores Cumulative promoters’ participation is to the tun

Bhagiradha Chemicals & Industries — H1FY26 Earnings Presentation on 6ix